DBV charts new path to market peanut allergy patch after Phase 3 success
DBV charts new path to market peanut allergy patch after Phase 3 success
DBV charts new path to market peanut allergy patch after Phase 3 success
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.